PALDA is an endocannabinoid with weak CB1 affinity.

Suspected endocannabinoid.

VDHP is a recently discovered endocannabinoid that acts as a CB1 agonist.

Suspected endocannabinoid. Does not bind classical endocannabinoid receptors (CB1/2) but targets GPR119.  

Suspected endocannabinoid.

STEARDA is an endocannabinoid with weak CB1 affinity.

OLDA is an endocannabinoid that weakly binds CB1 and GPR119 but has high affinity for TRPV1.

Suspected endocannabinoid.

Cannabichromanone D is a recently discovered cannabinoid. The physiological and therapeutic properties of Cannabichromanone B remain to be investigated.

Cannabichromanone B is a recently discovered cannabinoid. The physiological and therapeutic properties of Cannabichromanone B remain to be investigated.